11. Goodwill
(thousands of €) |
|
On 1 January 2013 |
37,667 |
|
|
Acquisition of subsidiaries |
1,572 |
|
|
On 31 December 2013 |
39,239 |
|
|
Sale of the service division |
(39,239) |
|
|
On 31 December 2014 |
|
Goodwill increased in 2013 and is related to the acquisition of Cangenix Ltd. (U.K.) by the service division on 4 January 2013.
The allocation of this goodwill through a Purchase Price Allocation (PPA) exercise has been performed in line with IFRS 3 and the outcome was that no purchase price was allocated to tangible or intangible assets, as the purchase was driven by acquiring skills relating to structured-based biology and not customer base or customer relationships.
The decrease of the goodwill to €0 was exclusively due to the sale of the service division to Charles River. The Group did not hold goodwill related to its continuing operations in its balance sheet.
|
Year ended 31 December, |
|
(thousands of €) |
2014 |
2013 |
Services – BioFocus |
|
29,040 |
Services – Argenta |
|
10,199 |
Total goodwill |
|
39,239 |